• Aucun résultat trouvé

[PDF] Top 20 Predicting, Preventing, and Managing Treatment-Related Complications in Patients With Inflammatory Bowel Diseases

Has 10000 "Predicting, Preventing, and Managing Treatment-Related Complications in Patients With Inflammatory Bowel Diseases" found on our website. Below are the top 20 most common "Predicting, Preventing, and Managing Treatment-Related Complications in Patients With Inflammatory Bowel Diseases".

Predicting, Preventing, and Managing Treatment-Related Complications in Patients With Inflammatory Bowel Diseases

Predicting, Preventing, and Managing Treatment-Related Complications in Patients With Inflammatory Bowel Diseases

... incidence in patients with rheumatoid arthritis who have had a prior malignancy: results from the British Society for Rheumatology Biologics ...among patients with rheumatoid arthritis ... Voir le document complet

32

Emerging Role of Exosomes in Diagnosis and Treatment of Infectious and Inflammatory Bowel Diseases

Emerging Role of Exosomes in Diagnosis and Treatment of Infectious and Inflammatory Bowel Diseases

... IBD patients contain higher amounts of IL-6, IL-8, IL-10 and TNF-α compared to exosomes from healthy subjects, and the levels of these pro-inflammatory molecules were positively correlated ... Voir le document complet

20

Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study.

Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study.

... differences in risk reduction by treatment with, respectively, thiopurines and anti-TNFs, which may be explained by a higher proportion of patients obtaining clinical and mucosal ... Voir le document complet

36

Association Between Reduced Plasma 25-Hydroxy Vitamin D and Increased Risk of Cancer in Patients With Inflammatory Bowel Diseases

Association Between Reduced Plasma 25-Hydroxy Vitamin D and Increased Risk of Cancer in Patients With Inflammatory Bowel Diseases

... described in detail in previous publications 19, 20 . In brief, we first identified all potential IBD patients by the presence of one or more International Classification of Diseases, 9 ... Voir le document complet

17

Emerging Role of Exosomes in Diagnosis and Treatment of Infectious and Inflammatory Bowel Diseases

Emerging Role of Exosomes in Diagnosis and Treatment of Infectious and Inflammatory Bowel Diseases

... IBD patients contain higher amounts of IL-6, IL-8, IL-10 and TNF-α compared to exosomes from healthy subjects, and the levels of these pro-inflammatory molecules were positively correlated ... Voir le document complet

21

A Potential Role of Salmonella Infection in the Onset of Inflammatory Bowel Diseases

A Potential Role of Salmonella Infection in the Onset of Inflammatory Bowel Diseases

... gene with a concomitant decreased protein level, display abnormal Paneth cells function due to a defect of the granule exocytosis ...observed in CD patients. In consequence, the secretion of ... Voir le document complet

13

View of Management of Patients with Inflammatory Bowel Disease Hospitalized in Intensive Care Unit

View of Management of Patients with Inflammatory Bowel Disease Hospitalized in Intensive Care Unit

... Les patients ayant une maladie inflammatoire chro- nique de l ’intestin (MICI) [maladie de Crohn ou rectocolite hémorragique] ont une probabilité plus importante d ’être hospitalisés en médecine intensive et ... Voir le document complet

8

Relevance and feasibility of a systematic screening of multimorbidities in patients with chronic inflammatory rheumatic diseases

Relevance and feasibility of a systematic screening of multimorbidities in patients with chronic inflammatory rheumatic diseases

... 200 patients were called 3-12 months after ...half patients performed vaccination (less for influenzae but this vaccine is seasonal) or consulted a specialist as requested ...(37.5–52.1%, with the ... Voir le document complet

7

Influence of disease location on Vedolizumab effectiveness in inflammatory bowel diseases: a real-life multicenter experience

Influence of disease location on Vedolizumab effectiveness in inflammatory bowel diseases: a real-life multicenter experience

... performed in a real life setting, highlights several key clinical observations on VDZ therapy in moderate to severe IBD patients, refractory to anti-TNF for the vast ...goal in IBD outcome ... Voir le document complet

47

Modulation of VIPergic phenotype of enteric neurons by colonic biopsy supernatants from patients with inflammatory bowel diseases: Involvement of IL-6 in Crohn's disease

Modulation of VIPergic phenotype of enteric neurons by colonic biopsy supernatants from patients with inflammatory bowel diseases: Involvement of IL-6 in Crohn's disease

... 19 In brief, the small intestines of rat embryos E15 (35‐45 per isolation) from three pregnant Sprague–Dawley rats (CERJ, Le Genest St Isle, France) were removed and finely diced in Hank's buffered ... Voir le document complet

16

Crohn's disease patients' and gastroenterologists' perspectives towards de-escalating inflammatory bowel disease therapy.

Crohn's disease patients' and gastroenterologists' perspectives towards de-escalating inflammatory bowel disease therapy.

... Conflicts of Interest: CA Siegel: Consultant/Advisory Board for Abbvie, Amgen, BMS, Celgene, Lilly, Janssen, Sandoz, Pfizer, Prometheus, Sebela, Takeda ; speaker for CME activities for Abbvie, Celgene, Janssen, Pfizer, ... Voir le document complet

7

Characterization of Human Colon Organoids From Inflammatory Bowel Disease Patients

Characterization of Human Colon Organoids From Inflammatory Bowel Disease Patients

... Canada Inflammatory Bowel Diseases (IBD) are chronic inflammatory disorders, where epithelial defects drive, at least in part, some of the ...morphological and functional ... Voir le document complet

14

Evidence for non-neutralizing autoantibodies against IL-10 signalling components in patients with inflammatory bowel disease.

Evidence for non-neutralizing autoantibodies against IL-10 signalling components in patients with inflammatory bowel disease.

... Results and discussion Antibodies against IL-10 Antibodies of the IgG isotype Sera of 20 healthy donors as well as 52 IBD patients were subjected to ELISA testing in search of anti-IL- 10 IgG ...IBD ... Voir le document complet

7

Complementary and alternative medicine in inflammatory bowel disease

Complementary and alternative medicine in inflammatory bowel disease

... Even though CAM seems to have no impact on adherence to conventional therapy, limiting the use of costly and potentially life-threatening drugs should be a priority for all clinicians. Contrary to popular belief, ... Voir le document complet

2

Intestinal dysbiosis in Inflammatory Bowel Disease associated with primary  immunodeficiency.

Intestinal dysbiosis in Inflammatory Bowel Disease associated with primary immunodeficiency.

... NCT02909244). Patients with IBD in remission were recruited at the Gastroenterology Department of the Saint Antoine Hospital (Paris, France) and provided informed consent (local ethics ... Voir le document complet

26

Brain-gut interactions in inflammatory bowel disease.

Brain-gut interactions in inflammatory bowel disease.

... irritable bowel syndrome (IBS) and inflammatory bowel diseases (IBD) have intersected across several domains despite having very distinct ...etiologies. In recent years there has ... Voir le document complet

53

Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects.

Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects.

... ATAs and Adalimumab (West 2008). Limits of ATI and ATA Notably, not only are the techniques for measurement of antibodies different, even the results obtained by the different methods are not reported ... Voir le document complet

41

Culturing human intestinal stem cells for regenerative applications in the treatment of inflammatory bowel disease

Culturing human intestinal stem cells for regenerative applications in the treatment of inflammatory bowel disease

... incidence and prevalence of inflammatory bowel disease (IBD) is increasing globally; in the industrialized world up to ...affected and around 4.2 million individuals suffer from IBD ... Voir le document complet

14

[Immunopathogenesis of inflammatory bowel disease.]

[Immunopathogenesis of inflammatory bowel disease.]

... des patients atteints de RCH est infiltrée majoritairement par des lymphocytes Th2 atypiques qui sont des lymphocytes caractérisés par la production d’IL5, d’IL13 et de TGF β ... Voir le document complet

13

CD4CD8aa Lymphocytes, A Novel Human Regulatory T Cell Subset Induced by Colonic Bacteria and Deficient in Patients with Inflammatory Bowel Disease

CD4CD8aa Lymphocytes, A Novel Human Regulatory T Cell Subset Induced by Colonic Bacteria and Deficient in Patients with Inflammatory Bowel Disease

... proportions and distinct subsets of double positive CD4CD8 T cells have been described in the blood of patients and healthy donors among which CD4CD8ab lymphocytes expressing high levels of ... Voir le document complet

17

Show all 10000 documents...